TBH Global Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $252K | Sell |
622
-22
| -3% | -$8.93K | 0.05% | 172 |
|
2025
Q1 | $320K | Buy |
644
+33
| +5% | +$16.4K | 0.06% | 152 |
|
2024
Q4 | $318K | Hold |
611
| – | – | 0.08% | 194 |
|
2024
Q3 | $378K | Hold |
611
| – | – | 0.08% | 185 |
|
2024
Q2 | $338K | Sell |
611
-60
| -9% | -$33.2K | 0.08% | 188 |
|
2024
Q1 | $390K | Buy |
671
+44
| +7% | +$25.6K | 0.08% | 182 |
|
2023
Q4 | $333K | Sell |
627
-20
| -3% | -$10.6K | 0.07% | 189 |
|
2023
Q3 | $328K | Hold |
647
| – | – | 0.06% | 196 |
|
2023
Q2 | $338K | Hold |
647
| – | – | 0.07% | 184 |
|
2023
Q1 | $373K | Sell |
647
-16
| -2% | -$9.22K | 0.08% | 162 |
|
2022
Q4 | $365K | Hold |
663
| – | – | 0.09% | 133 |
|
2022
Q3 | $336K | Buy |
663
+30
| +5% | +$15.2K | 0.09% | 134 |
|
2022
Q2 | $344K | Hold |
633
| – | – | 0.08% | 143 |
|
2022
Q1 | $374K | Sell |
633
-1,140
| -64% | -$674K | 0.08% | 145 |
|
2021
Q4 | $1.18M | Sell |
1,773
-34
| -2% | -$22.7K | 0.25% | 72 |
|
2021
Q3 | $1.03M | Hold |
1,807
| – | – | 0.24% | 79 |
|
2021
Q2 | $911K | Sell |
1,807
-185
| -9% | -$93.3K | 0.21% | 82 |
|
2021
Q1 | $909K | Buy |
1,992
+69
| +4% | +$31.5K | 0.24% | 78 |
|
2020
Q4 | $896K | Sell |
1,923
-314
| -14% | -$146K | 0.28% | 68 |
|
2020
Q3 | $988K | Buy |
2,237
+1,581
| +241% | +$698K | 0.34% | 60 |
|
2020
Q2 | $238K | Buy |
+656
| New | +$238K | 0.09% | 137 |
|